Core Viewpoint - The document outlines the information disclosure management system of Shanghai Sanyou Medical Co., Ltd., emphasizing the importance of timely, accurate, and complete disclosure of significant information that may impact stock trading prices and investment decisions [1][2]. Group 1: Information Disclosure Principles - Information disclosure is a continuous responsibility of the company, requiring adherence to laws, regulations, and stock exchange rules [9][10]. - The company must ensure that all disclosed information is true, accurate, complete, and timely, allowing equal access for all investors [10][16]. - Disclosure documents should be clear, concise, and free from misleading statements or omissions [8][9]. Group 2: Types of Disclosable Information - Significant information includes financial performance, profit forecasts, mergers and acquisitions, major investments, and legal matters [3][4]. - The company must disclose any information that could significantly affect stock prices or investment decisions, including major contracts and government approvals [2][3]. - Information related to stock issuance, repurchase, and incentive plans must also be disclosed [3][4]. Group 3: Disclosure Procedures - The board of directors is responsible for overseeing the information disclosure process, with the secretary of the board coordinating the specific activities [57][58]. - All disclosures must be submitted to the Shanghai Stock Exchange and made available to the public [4][10]. - The company must correct any previously disclosed information that is found to be erroneous or misleading [64]. Group 4: Responsibilities of Disclosure Obligors - The chairman of the board is the ultimate responsible person for information disclosure, and all relevant parties must comply with disclosure obligations [7][10]. - Individuals involved in the disclosure process must ensure that the information is kept confidential until officially disclosed [10][11]. - The company must maintain a record of insider information and ensure that insider trading does not occur [32][34].

Group 1 - The company establishes a system for timely, accurate, and complete information disclosure to protect investors' rights, in accordance with relevant laws and regulations [1][4][8] - Major information that must be disclosed includes financial performance, mergers and acquisitions, stock issuance, and significant operational matters [1][4][6] - The board of directors and senior management are responsible for ensuring the accuracy and completeness of disclosed information [4][10][12] Group 2 - Information disclosure is a continuous responsibility, requiring the company to disclose all information that may significantly impact stock prices or investment decisions [4][8][9] - The company must use clear and straightforward language in announcements, avoiding jargon and promotional language [3][9][10] - All investors must have equal access to disclosed information, and the company must not selectively disclose information to certain investors [4][14][15] Group 3 - The company must disclose periodic reports, including annual, semi-annual, and quarterly reports, which must be audited by qualified accounting firms [9][11][12] - Timely disclosure of significant events is required, including board resolutions, related party transactions, and other major occurrences [9][14][18] - The company must ensure that any performance forecasts or financial predictions are reasonable and based on factual information [12][13][14] Group 4 - The company must disclose any major litigation or arbitration that could significantly affect its operations or financial status [20][22][24] - Any changes in the company's capital structure, such as stock issuance or changes in shareholder rights, must be disclosed promptly [22][23][24] - The company is required to disclose any risks that may significantly impact its financial health or operational stability [25][26][27]

General Principles - The information disclosure management system is established to standardize the disclosure behavior of Beijing Wandong Medical Technology Co., Ltd., protect the legal rights of the company and its shareholders, and ensure the authenticity, accuracy, completeness, timeliness, and fairness of disclosed information [2][3]. - The term "information" refers to any information that may significantly impact the company's stock price and information required by regulatory authorities [3]. Responsibilities of Disclosure Parties - The board of directors is responsible for leading and managing information disclosure affairs, with the board secretary coordinating and organizing these activities [8][9]. - All directors and senior management are responsible for the content of information disclosures, ensuring that the information is true, accurate, complete, timely, and fair [8][10]. Disclosure Principles and Standards - The company must adhere to the principles of authenticity, timeliness, completeness, accuracy, and fairness in its information disclosures [16][10]. - Information must be disclosed through designated channels and in accordance with strict procedures to ensure reliability and prevent any form of falsification [16]. Reporting Procedures - Regular reports, including annual, semi-annual, and quarterly reports, must be prepared and disclosed within specified timeframes [18][12]. - The company must report and announce significant transactions within two working days if they meet the standards set by the listing rules [20]. Confidentiality Measures - All major information is considered insider information and must be reported and circulated internally according to the established procedures before public disclosure [34][19]. - Individuals with access to insider information are required to maintain confidentiality and are prohibited from disclosing such information before it is officially released [19][20]. Training and Compliance - The board secretary is responsible for organizing training on the information disclosure system for relevant personnel [64]. - The company must ensure compliance with national laws, regulations, and the listing rules regarding information disclosure [27].